Brief: AtriCure Q2 Adjusted EPS USD -0.17 Vs. IBES Estimate USD -0.17
30/07/2024 21:01
Jul 30 (Reuters) - AtriCure Q2 gross margin 74.7%. * Q2 operating income USD -7.2 million vs. IBES estimate USD -6.7 million * Q2 adjusted EBITDA USD 7.8 million vs. IBES estimate USD 7.41 million * Q2 revenue USD 116.3 million vs. IBES estimate USD 116.2 million * Q2 gross profit USD 86.8 million * outlook FY adjusted EBITDA USD 26-29 million * outlook FY adjusted EPS USD -0.82 to -0.74
Recent news on AtriCure
See all newsBrief: Inspire Medical Systems, Inc. Announces Appointment Of Seasoned Medical Device Executive Michael H. Carrel To Its Board Of Directors
AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary
AtriCure Q2 revenue beats estimates
Brief: AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
AtriCure Q1 revenue beats estimates, co raises 2026 outlook